Skip to main content
. 2022 May 3;36(3):1461–1467. doi: 10.21873/invivo.12852

Table II. Accuracy of MIS in the incidence of various grades of hematologic and non-hematologic ADRs in patients who received R-CHOP chemotherapy.

graphic file with name in_vivo-36-1464-i0001.jpg

ADRs: Adverse drug reactions; ALT: alanine aminotransferase; AST: aspartate aminotransferase; MIS: medication instruction sheet; R-CHOP: rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone. Numbers in parentheses represent the incidence rate.